{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:45:19Z","timestamp":1767926719887,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ae0101074s0401"],"award-info":[{"award-number":["19ae0101074s0401"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K19960"],"award-info":[{"award-number":["18K19960"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K19960"],"award-info":[{"award-number":["18K19960"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CG\/013\/2013"],"award-info":[{"award-number":["NMRC\/CG\/013\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CIRG\/1491\/2018"],"award-info":[{"award-number":["NMRC\/CIRG\/1491\/2018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["OFLCG18May-0028"],"award-info":[{"award-number":["OFLCG18May-0028"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41375-022-01655-5","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T07:03:05Z","timestamp":1659164585000},"page":"2293-2305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia"],"prefix":"10.1038","volume":"36","author":[{"given":"Jolynn Zu Lin","family":"Ong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yokomori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina Wan Ju","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-615X","authenticated-orcid":false,"given":"Tze King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-1142","authenticated-orcid":false,"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-0777","authenticated-orcid":false,"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-4954","authenticated-orcid":false,"given":"Takaomi","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/sj.onc.1210368","volume":"26","author":"TA Waldmann","year":"2007","unstructured":"Waldmann TA. Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia\/lymphoma. Oncogene. 2007;26:3699\u2013703.","journal-title":"Oncogene"},{"key":"1655_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang K-T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270\u201380.","journal-title":"Nat Rev Cancer"},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15:517\u201326.","journal-title":"Lancet Oncol"},{"key":"1655_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.coviro.2015.09.004","volume":"14","author":"CR Bangham","year":"2015","unstructured":"Bangham CR, Ratner L. How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)? Curr Opin Virol. 2015;14:93\u2013100.","journal-title":"Curr Opin Virol"},{"key":"1655_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","volume":"129","author":"T Watanabe","year":"2017","unstructured":"Watanabe T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood. 2017;129:1071\u201381.","journal-title":"Blood"},{"key":"1655_CR6","first-page":"2326","volume":"130","author":"RWJ Wong","year":"2017","unstructured":"Wong RWJ, Ngoc PCT, Leong WZ, Yam AWY, Zhang T, Asamitsu K, et al. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood, J Am Soc Hematol. 2017;130:2326\u201338.","journal-title":"Blood, J Am Soc Hematol"},{"key":"1655_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1182\/blood.2019002639","volume":"135","author":"RWJ Wong","year":"2020","unstructured":"Wong RWJ, Tan TK, Amanda S, Ngoc PCT, Leong WZ, Tan SH, et al. Feed-forward regulatory loop driven by IRF4 and NF-\u03baB in adult T-cell leukemia\/lymphoma. Blood. 2020;135:934\u201347.","journal-title":"Blood"},{"key":"1655_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J-I, et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015;47:1304\u201315.","journal-title":"Nat Genet"},{"key":"1655_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1182\/blood.2021013568","volume":"139","author":"Y Kogure","year":"2022","unstructured":"Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga J-I, et al. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood. 2022;139:967\u201382.","journal-title":"Blood"},{"key":"1655_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/35043127","volume":"1","author":"A Yang","year":"2000","unstructured":"Yang A, McKeon F. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol cell Biol. 2000;1:199\u2013207.","journal-title":"Nat Rev Mol cell Biol"},{"key":"1655_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrc861","volume":"2","author":"G Melino","year":"2002","unstructured":"Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer. 2002;2:605\u201315.","journal-title":"Nat Rev Cancer"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/21690","volume":"399","author":"J Gong","year":"1999","unstructured":"Gong J, Costanzo A, Yang H-Q, Melino G, Kaelin WG, Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999;399:806\u20139.","journal-title":"Nature"},{"key":"1655_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.onc.1203512","volume":"19","author":"S-W Ng","year":"2000","unstructured":"Ng S-W, Yiu GK, Liu Y, Huang L-W, Palnati M, Jun SH, et al. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene. 2000;19:1885\u201390.","journal-title":"Oncogene"},{"key":"1655_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1054\/bjoc.2001.2138","volume":"85","author":"J O\u2019nions","year":"2001","unstructured":"O\u2019nions J, Brooks L, Sullivan A, Bell A, Dunne B, Rozycka M, et al. p73 is over-expressed in vulval cancer principally as the \u03b4 2 isoform. Br J Cancer. 2001;85:1551\u20136.","journal-title":"Br J Cancer"},{"key":"1655_CR15","first-page":"3257","volume":"59","author":"AI Zaika","year":"1999","unstructured":"Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res. 1999;59:3257\u201363.","journal-title":"Cancer Res"},{"key":"1655_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.cdd.4400962","volume":"8","author":"T Grob","year":"2001","unstructured":"Grob T, Novak U, Maisse C, Barcaroli D, L\u00fcthi A, Pirnia F, et al. Human \u0394Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 2001;8:1213\u201323.","journal-title":"Cell Death Differ"},{"key":"1655_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.cdd.4400993","volume":"9","author":"I Casciano","year":"2002","unstructured":"Casciano I, Mazzocco K, Boni L, Pagnan G, Banelli B, Allemanni G, et al. Expression of \u0394Np73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ. 2002;9:246\u201351.","journal-title":"Cell Death Differ"},{"key":"1655_CR18","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1158\/0008-5472.CAN-03-1060","volume":"64","author":"N Concin","year":"2004","unstructured":"Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, et al. Transdominant \u0394TAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res. 2004;64:2449\u201360.","journal-title":"Cancer Res"},{"key":"1655_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1158\/1078-0432.CCR-0153-03","volume":"10","author":"T Stiewe","year":"2004","unstructured":"Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, P\u00fctzer BM. Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin Cancer Res. 2004;10:626\u201333.","journal-title":"Clin Cancer Res"},{"key":"1655_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","volume":"511","author":"N Kwiatkowski","year":"2014","unstructured":"Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature. 2014;511:616\u201320.","journal-title":"Nature"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/416560a","volume":"416","author":"ER Flores","year":"2002","unstructured":"Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002;416:560\u20134.","journal-title":"Nature"},{"key":"1655_CR22","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1096\/fj.11-192815","volume":"25","author":"E Zaika","year":"2011","unstructured":"Zaika E, Wei J, Yin D, Andl C, Moll U, El\u2010Rifai W, et al. p73 protein regulates DNA damage repair. FASEB J. 2011;25:4406\u201314.","journal-title":"FASEB J"},{"key":"1655_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/21697","volume":"399","author":"R Agami","year":"1999","unstructured":"Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73\u03b1 and their collaboration to induce apoptosis. Nature. 1999;399:809\u201313.","journal-title":"Nature"},{"key":"1655_CR24","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1128\/MCB.22.8.2575-2585.2002","volume":"22","author":"T Nakagawa","year":"2002","unstructured":"Nakagawa T, Takahashi M, Ozaki T, Watanabe K-I, Todo S, Mizuguchi H, et al. Autoinhibitory regulation of p73 by \u0394Np73 to modulate cell survival and death through a p73-specific target element within the \u0394 Np73 promoter. Mol Cell Biol. 2002;22:2575\u201385.","journal-title":"Mol Cell Biol"},{"key":"1655_CR25","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"A Kinner","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. \u03b3-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008;36:5678\u201394.","journal-title":"Nucleic Acids Res"},{"key":"1655_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. \u03b3H2AX and cancer. Nat Rev Cancer. 2008;8:957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"1655_CR27","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","volume":"24","author":"R Grassmann","year":"2005","unstructured":"Grassmann R, Aboud M, Jeang K-T. Molecular mechanisms of cellular transformation by HTLV-1 tax. Oncogene. 2005;24:5976\u201385.","journal-title":"Oncogene"},{"key":"1655_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2005.09.036","volume":"123","author":"S Janssens","year":"2005","unstructured":"Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-\u03baB activation in response to DNA damage. Cell. 2005;123:1079\u201392.","journal-title":"Cell"},{"key":"1655_CR29","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","volume":"27","author":"T Nakayama","year":"2008","unstructured":"Nakayama T, Hieshima K, Arao T, Jin Z, Nagakubo D, Shirakawa A, et al. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia. Oncogene. 2008;27:3221\u201332.","journal-title":"Oncogene"},{"key":"1655_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","volume":"34","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa M, Shaffer AL, Ceribelli M, Zhang M, Wright G, Huang DW, et al. Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma. Cancer Cell. 2018;34:286\u2013297.e210.","journal-title":"Cancer Cell"},{"key":"1655_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/35003607","volume":"404","author":"A Yang","year":"2000","unstructured":"Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000;404:99\u2013103.","journal-title":"Nature"},{"key":"1655_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/sj.cdd.4400631","volume":"6","author":"S Ikawa","year":"1999","unstructured":"Ikawa S, Nakagawara A, Ikawa Y. p53 family genes: structural comparison, expression and mutation. Cell Death Differ. 1999;6:1154\u201361.","journal-title":"Cell Death Differ"},{"key":"1655_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0168-9525(02)02595-7","volume":"18","author":"A Yang","year":"2002","unstructured":"Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. TRENDS Genet. 2002;18:90\u201395.","journal-title":"TRENDS Genet"},{"key":"1655_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozreti\u0107 L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47\u201353.","journal-title":"Nature"},{"key":"1655_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211\u20138.","journal-title":"Nat Genet"},{"key":"1655_CR36","first-page":"1481","volume":"52","author":"N Kamada","year":"1992","unstructured":"Kamada N, Sakurai M, Miyamoto K, Sanada I, Sadamori N, Fukuhara S, et al. Chromosome abnormalities in adult T-cell leukemia\/lymphoma: a karyotype review committee report. Cancer Res. 1992;52:1481\u201393.","journal-title":"Cancer Res"},{"key":"1655_CR37","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","volume":"97","author":"K Tsukasaki","year":"2001","unstructured":"Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR, et al. Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: correlation with clinical course. Blood. 2001;97:3875\u201381.","journal-title":"Blood"},{"key":"1655_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307\u201319.","journal-title":"Cell"},{"key":"1655_CR39","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andr\u00e9 V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934\u201347.","journal-title":"Cell"},{"key":"1655_CR40","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.1073\/pnas.88.23.10431","volume":"88","author":"H Miyoshi","year":"1991","unstructured":"Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t (8; 21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA. 1991;88:10431\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1655_CR41","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/stem.507","volume":"28","author":"CE Ng","year":"2010","unstructured":"Ng CE, Yokomizo T, Yamashita N, Cirovic B, Jin H, Wen Z, et al. A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells. 2010;28:1869\u201381.","journal-title":"Stem Cells"},{"key":"1655_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature07619","volume":"457","author":"MJ Chen","year":"2009","unstructured":"Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature. 2009;457:887\u201391.","journal-title":"Nature"},{"key":"1655_CR43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1128\/MCB.16.4.1349","volume":"16","author":"SW Hiebert","year":"1996","unstructured":"Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, et al. The t (12; 21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol. 1996;16:1349\u201355.","journal-title":"Mol Cell Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01655-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:04:38Z","timestamp":1661508278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1038\/s41375-022-01655-5","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RU reports receiving research funding from Kyowa Kirin, Chugai and Ono Pharmaceutical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}